These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 29113750)

  • 21. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
    Klokkaris A; Migdalska-Richards A
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
    Iraola-Guzmán S; Estivill X; Rabionet R
    Clin Genet; 2011 Jul; 80(1):1-14. PubMed ID: 21542837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.
    Basavarajappa BS; Subbanna S
    Epigenomics; 2024 Mar; 16(5):331-358. PubMed ID: 38321930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic clocks in neurodegenerative diseases: a systematic review.
    Yang T; Xiao Y; Cheng Y; Huang J; Wei Q; Li C; Shang H
    J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1064-1070. PubMed ID: 36963821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity.
    Hung CC; Lee YH; Kuo YM; Hsu PC; Tsay HJ; Hsu YT; Lee CC; Liang JJ; Shie FS
    J Neuroinflammation; 2019 Jun; 16(1):123. PubMed ID: 31176371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epigenetics and etiology of neurodegenerative diseases].
    Gruber BM
    Postepy Hig Med Dosw (Online); 2011 Aug; 65():542-51. PubMed ID: 21918257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic mechanisms in Parkinson's disease.
    Feng Y; Jankovic J; Wu YC
    J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies.
    Renani PG; Taheri F; Rostami D; Farahani N; Abdolkarimi H; Abdollahi E; Taghizadeh E; Gheibi Hayat SM
    J Cell Physiol; 2019 Nov; 234(11):19307-19319. PubMed ID: 30968426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
    De Plano LM; Saitta A; Oddo S; Caccamo A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic nutraceutical diets in Alzheimer's disease.
    Davinelli S; Calabrese V; Zella D; Scapagnini G
    J Nutr Health Aging; 2014 Nov; 18(9):800-5. PubMed ID: 25389957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocyte senescence: Evidence and significance.
    Cohen J; Torres C
    Aging Cell; 2019 Jun; 18(3):e12937. PubMed ID: 30815970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic Regulation of Neuroinflammation in Alzheimer's Disease.
    Ma Y; Wang W; Liu S; Qiao X; Xing Y; Zhou Q; Zhang Z
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases.
    Wang Y; Yang Y; Zhang S; Li C; Zhang L
    Neurobiol Aging; 2020 Mar; 87():1-10. PubMed ID: 31986345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic programming of neurodegenerative diseases by an adverse environment.
    Babenko O; Kovalchuk I; Metz GA
    Brain Res; 2012 Mar; 1444():96-111. PubMed ID: 22330722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic Regulation of the Hippocampus, with Special Reference to Radiation Exposure.
    Saw G; Tang FR
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic Basis of Lead-Induced Neurological Disorders.
    Wang T; Zhang J; Xu Y
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32645824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
    Lee PS; Chiou YS; Ho CT; Pan MH
    Biofactors; 2018 Jan; 44(1):26-35. PubMed ID: 29220106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.